79 235

Cited 0 times in

Estimated Prostate Cancer Prevalence in Korean Men with Serum Prostate-specific Antigen 2.5-9.9ng/ml

Other Title
혈청 전립선특이항원 2.5-9.9ng/ml인 한국인에서 전립선암 유병률 추정
조, 진선; 김, 선일; 김, 세중; 김, 영식; 김, 천일; 김, 홍섭; 성, 도환; 송, 윤섭; 이, 동현; 양, 원재; 전, 상현; 조, 강수; 조, 인래; 정, 병하; 최, 영득; 임, 형준; 홍, 성준
Korean Journal of Urological Oncology, 5(3):144-147, 2007
Journal Title
Korean Journal of Urological Oncology; 대한비뇨기종양학회지
Purpose: The aim of this study was to estimate the number of prevalent cases of biopsy detectable prostate cancer in Korean men with prostate-specific antigen(PSA) 2.5-9.9ng/ml.

Materials and Methods :We analyzed 2,422 Korean men who had undergone prostate biopsy at 11 medical centers from 1993 to 2002. A total of 45,074 men(aged 50 to 79 years) carried out serum PSA level test at routine physical check-ups, between 1999 and 2005, at 12 domestic hospitals. We combined these results with published data from Korean population census in 2005, and calculated the prostate cancer prevalence in Korean men with PSA 2.5-9.9ng/ml.

Results: There are estimated 94,900(1.9%) and 34,500(0.7%) prevalent cases of biopsy detectable prostate cancer in men aged 50-79 years with a serum PSA 2.5-9.9ng/ml and 4.0-9.9ng/ml, respectively.

Conclusions :A large number of prevalent cases of biopsy detectable prostate cancer exist in Korean men with PSA 2.5-9.9ng/ml. This information is useful for patient counseling and provides strategy for PSA screening.
Prostate-specific antigenPrevalenceProstate NeoplasmScreening
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Urology
AJOU Authors
김, 선일김, 세중
Files in This Item:
RIS (EndNote)
XLS (Excel)


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.